表紙
市場調査レポート

胃癌:主要17カ国市場の予測

Stomach Cancer Forecast In 17 Major Markets 2016-2026

発行 Black Swan Analysis 商品コード 353991
出版日 ページ情報 英文 66 pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
胃癌:主要17カ国市場の予測 Stomach Cancer Forecast In 17 Major Markets 2016-2026
出版日: 2016年03月09日 ページ情報: 英文 66 pages
概要

当レポートでは、世界の主要17カ国市場における胃癌の有病人口について調査し、性別・年齢コホート別の内訳、ステージとグレード、部位、腫瘍細胞の組織病理学、リスク因子、疾患の診断と予後、地域や民族による違いなど、体系的な情報を提供しています。

図表

イントロダクション

病因

リスク因子と予防

疾患の診断

地域/民族による違い

疾患予後と臨床経過

主な併存症/疾患に関連する特徴

患者数を定量化する手法

胃癌の有病数トップライン

胃癌のステージとグレード

  • 部位
  • 胃癌の腫瘍細胞の組織病理学
  • 胃癌のLauren分類
  • 胃癌とピロリ感染の併存

略語

関連出版

患者ベースのオンラインデータベース

患者ベースの製品

価格のオンラインデータ・プラットフォーム

参考文献

付録

調査対象国

  • 米国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • 英国
  • ブラジル
  • 日本
  • カナダ
  • オーストラリア
  • インド
  • メキシコ
  • トルコ
  • 南アフリカ
  • サウジアラビア
  • アルゼンチン
  • ロシア
目次
Product Code: STOM0010316

image1

Stomach cancer is a broad term encompassing tumours arising in the stomach. Includes gastric carcinoma which is a malignant epithelial-origin tumour commonly developing after prolonged period of gastritis. Stomach cancers tend to develop slowly over many years spreading in different ways. Staging for stomach cancer is as per AJCC stage at diagnosis and Lauren classification for Adenocarcinoma.

This report provides the current incidence population for Stomach Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, Canada, Australia, India, Mexico, Turkey, South Africa, Saudi Arabia, Argentina and Russia) split by gender and 5-year age cohort. Along with the current incidence, the report provides an overview of the stages, locations and histopathology of Stomach Cancer tumours. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms of Stomach Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Stomach Cancer include:

  • History of stomach polyps or stomach lymphoma
  • Family history of stomach cancer
  • Family history of hereditary non-polyposis
  • Colorectal cancer
  • Familial adenomatous polyposis
  • BRCA1 or BRCA2 mutations
  • Megaloblastic (pernicious) anaemia or being blood type A.

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Stomach Cancer market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the incidence of the subdivided types of Stomach Cancer and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Stomach Cancer incidence
  • Identify sub-populations within Stomach Cancer which require treatment.
  • Gain an understanding of the specific markets that have the largest number Stomach Cancer patients

COVERAGE

US, UK, FR, DE, IT, ES, JP, BR, IN, TR, CA, AU, AR, RU, MX, ZA, SA

image2

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

Key Co-morbid Conditions/ Features Associated with the Disease

Methodology for Quantification of Patient Numbers

  • Additional data available on request

Top-Line Incidence for Stomach Cancer

Stages and Grading of Stomach Cancer

  • Location of Tumour
  • Histopathology of Tumour Cells in Stomach Cancer
  • Lauren Classification of Stomach Cancer
  • Co-morbidity of H. Pylori infection in Stomach Cancer

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables

  • AJCC Tumour Grading Classification for Stomach Cancer
  • Incidence of Stomach Cancer, total (000s)
  • Incidence of Stomach Cancer, males (000s)
  • Incidence of Stomach Cancer, females (000s)
  • AJCC Stage at diagnosis for Stomach cancer patients, total (000s)
  • Location of tumour cells in Stomach Cancer patients, total (000s)
  • Major histopathological type of Stomach Cancer, total (000s)
  • Lauren Classification of Adenocarcinoma subtypes in SC patients, total (000s)
  • Pylori infection in Stomach cancer, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • USA Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • France Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • France Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Germany Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Germany Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Italy Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Italy Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Spain Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Spain Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • United Kingdom Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • United Kingdom Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Brazil Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Brazil Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Japan Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Japan Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • India Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • India Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Mexico Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Mexico Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Turkey Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Turkey Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Argentina Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Argentina Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Australia Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Australia Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Canada Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Canada Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Russia Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Russia Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Saudi Arabia Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Saudi Arabia Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • South Africa Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • South Africa Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
Back to Top